UK: NHS Approve Epidyolex & Sativex For Specific Conditions

Two medicines derived from the cannabis plant have been recommended for use on the NHS for the first time.

Epidyolex has been approved for two rare types of epilepsy, Lennox-Gastaut and Dravet syndromes, while the spray Sativex has been recommended for muscle spasms in multiple sclerosis (MS).

Charities welcomed the move, but said thousands of other people with a range of conditions who could benefit from cannabis-based medicines were left in limbo.

The National Institute for Health and Care Excellence (Nice) has ruled out prescribing drugs containing THC (delta-9-tetrahydrocannabinol) – the psychoactive ingredient in cannabis – to treat chronic pain.

It also said more research was needed on cannabis-based medicines to treat forms of epilepsy other than Lennox-Gastaut and Dravet.

More at Sky News (UK)  https://news.sky.com/story/cannabis-based-drugs-to-help-epilepsy-and-ms-approved-for-nhs-use-11859209

Comments are closed.

× Order via Whatsapp?